Intrinsic Value of S&P & Nasdaq Contact Us

DexCom, Inc. DXCM NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
82/100
7/7 Pass
SharesGrow Intrinsic Value
$98.26
+56.1%
Analyst Price Target
$85.82
+36.3%

Stock Statistics — DXCM

DexCom, Inc. (DXCM) has a market capitalization of $24.55B and trades at $62.95. The 52-week range is 54.11-89.98.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 29.4, Earnings Per Share (EPS) of $2.14, annual revenue of $4.66B.

The stock has a beta of 1.56, operates in the Healthcare sector.

Trading Data
Current Price$62.95
52-Week Range54.11-89.98
Volume4.42M
Avg Volume (30D)4.7M
Market Cap$24.55B
Beta (1Y)1.56
Company
IPO Date2005-04-14
Employees10,200
CEOJacob Steven Leach
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS2521311074
CUSIP252131107
Income (Latest Year)
Revenue$4.66B
Gross Profit$2.8B
EBITDA$1.16B
Operating Income$911.8M
Net Income$836.3M
EPS$2.14
EPS Diluted$2.09
Shares Outstanding$390.2M
Balance Sheet (Latest Year)
Total Assets$6.34B
Current Assets$4.03B
Cash & ST Investments$2B
Total Liabilities$3.59B
Total Debt$1.39B
Net Debt$472M
Total Equity$2.75B
Debt / Equity0.51
Valuation Ratios
P/E Ratio29.4
P/S Ratio5.27
P/B Ratio8.94
EV/EBITDA (approx)21.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message